MRC1 and colorectal cancer: The [111In]In-bisRu(dppz) (113) radiocomplex, showing a higher affinity towards mismatch DNA over well-matched sequences, can target the nuclei of MMR-deficient cancer cells and exhibited a preferential radiotoxicity against this cell line when compared with MMR-deficient human colorectal cancer cells.